Neurogene
NGNE
NGNE
40 hedge funds and large institutions have $314M invested in Neurogene in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.15% less ownership
Funds ownership: 4.92% → 4.77% (-0.15%)
18% less capital invested
Capital invested by funds: $384M → $314M (-$70.2M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
40
Holding in Top 10
1
Calls
$256K
Puts
$115K
Top Buyers
| 1 | +$3.02M | |
| 2 | +$2.41M | |
| 3 | +$1.85M | |
| 4 |
NC
Nexthera Capital
New York
|
+$1.28M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.06M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$4.96M | |
| 3 | -$3.21M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.42M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$430K |